ARCHIVES

Aging Committee Hears Prospects For Immunotherapy

This article is from The Cancer Letter archive.

Vol. 05 No. 30 | July 27, 1979

Download PDF Visit The Full Archive

Related Articles

FDA News:: ODAC Commends Ciba For Design Of Trials Legal Issues:

January 10, 1997

Olaparib, A PARP Inhibitor, Can Reduce Tumor Size In Advanced Ovarian Cancer

August 27, 2010

In Brief: Columbia’s Marks Said To Be Cancer Panel New Member; Eight VCP Cregs Awarded

April 2, 1976

In a letter, ASCO reaffirms its views on oncology consolidation at FDA.

July 9, 2004

Slow Accruing Trials Should Be Removed From High Priority Program, Broder Says

October 2, 1992

A Misdirected Email: CPRIT Official Speaks of “New Regime” As Institute Denies Deepening Crisis

October 19, 2012